{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T14:38:45Z","timestamp":1753886325136},"reference-count":16,"publisher":"Kurume Medical Journal","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Kurume Med. J."],"published-print":{"date-parts":[[2019,6,30]]},"DOI":"10.2739\/kurumemedj.ms662004","type":"journal-article","created":{"date-parts":[[2021,6,14]],"date-time":"2021-06-14T22:11:03Z","timestamp":1623708663000},"page":"127-133","source":"Crossref","is-referenced-by-count":3,"title":["Infective Endocarditis Following Chicken Pox: A Rare Association"],"prefix":"10.2739","volume":"66","author":[{"given":"MANASVINI","family":"BHATT","sequence":"first","affiliation":[{"name":"Department of Medicine, All India Institute of Medical Sciences"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"NITIN","family":"GUPTA","sequence":"additional","affiliation":[{"name":"Department of Medicine, All India Institute of Medical Sciences"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"MANISH","family":"SONEJA","sequence":"additional","affiliation":[{"name":"Department of Medicine, All India Institute of Medical Sciences"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"UJJWALKUMAR S","family":"DAS","sequence":"additional","affiliation":[{"name":"Department of Ocular Pharmacology and Pharmacy, All India Institute of Medical Sciences"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"VELPANDIAN","family":"THIRUMURTHY","sequence":"additional","affiliation":[{"name":"Department of Ocular Pharmacology and Pharmacy, All India Institute of Medical Sciences"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"ASHUTOSH","family":"BISWAS","sequence":"additional","affiliation":[{"name":"Department of Medicine, All India Institute of Medical Sciences"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1445","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Kang J-H, Sheu J-J, and Lin H-C. Increased Risk of Guillain-Barr\u00e9 Syndrome following Recent Herpes Zoster: A Population-Based Study across Taiwan. Clin Infect Dis 2010; 51(5):525-530.","DOI":"10.1086\/655136"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Abrams D, Derrick G, Penny DJ, Shinebourne EA, and Redington AN. Cardiac complications in children following infection with varicella zoster virus. Cardiol Young 2001; 11(6):647-652.","DOI":"10.1017\/S1047951101001019"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Bhatt DD, Kharkwal N, and Yadav DK. Staphylococcal endocarditis after chicken pox in a child with structurally normal heart. Ann Pediatr Cardiol 2017; 10(3):312-313.","DOI":"10.4103\/apc.APC_17_17"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Cresswell F, Eadie J, Longley N, and Macallan D. Severe Guillain-Barr\u00e9 syndrome following primary infection with varicella zoster virus in an adult. Int J Infect Dis 2010; 14(2):161-163.","DOI":"10.1016\/j.ijid.2009.03.019"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Grahn A, Studahl M. Varicella-zoster virus infections of the central nervous system - Prognosis, diagnostics and treatment. J Infect 2015; 71(3):281-293.","DOI":"10.1016\/j.jinf.2015.06.004"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Chiang F, Panyaping T, Tedesqui G, Sossa D, Costa Leite C et al. Varicella zoster CNS vascular complications. A report of four cases and literature review. Neuroradiol J 2014; 27(3):327-333.","DOI":"10.15274\/NRJ-2014-10037"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Wojda TR, Cornejo K, Lin A, Cipriano A, Nanda S et al. Septic Embolism: A Potentially Devastating Complication of Infective Endocarditis. Contemporary Challenges in Endocarditis 2016; 143-167.","DOI":"10.5772\/64931"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Miro JM, Anguera I, Cabell CH, Chen AY, Stafford JA et al. Staphylococcus aureus Native Valve Infective Endocarditis: Report of 566 Episodes from the International Collaboration on Endocarditis Merged Database. Clin Infect Dis 2005; 41(4):507-514.","DOI":"10.1086\/431979"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Ortwine JK and Bhavan K. Morbidity, mortality, and management of methicillin-resistant S. aureus bacteremia in the USA: update on antibacterial choices and understanding. Hosp Pract 2018; 46(2):64-72.","DOI":"10.1080\/21548331.2018.1435128"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Pfausler B, Spiss H, Beer R, Kampl A, Engelhardt K et al. Treatment of staphylococcal ventriculitis associated with external cerebrospinal fluid drains: a prospective randomized trial of intravenous compared with intraventricular vancomycin therapy. J Neurosurg 2003; 98(5):1040-1044.","DOI":"10.3171\/jns.2003.98.5.1040"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Nakayama H, Echizen H, Tanaka M, Sato M, and Orii T. Reduced vancomycin clearance despite unchanged creatinine clearance in patients treated with vancomycin for longer than 4 weeks. Ther Drug Monit 2008; 30(1):103-107.","DOI":"10.1097\/FTD.0b013e318164f781"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Fowler VG, Boucher HW, Corey GR, Abrutyn E, Karchmer AW et al. Daptomycin versus standard therapy for bacteremia and endocarditis caused by Staphylococcus aureus. N Engl J Med 2006; 355(7):653-665.","DOI":"10.1056\/NEJMoa053783"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Carugati M, Bayer AS, Mir\u00f3 JM, Park LP, Guimar\u00e3es AC et al. High-Dose Daptomycin Therapy for Left-Sided Infective Endocarditis: a Prospective Study from the International Collaboration on Endocarditis. Antimicrob Agents Chemother 2013; 57(12):6213-6222.","DOI":"10.1128\/AAC.01563-13"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Marco F, Garc\u00eda de la M\u00e0ria C, Armero Y, Amat E, Soy D et al. Daptomycin Is Effective in Treatment of Experimental Endocarditis Due to Methicillin-Resistant and Glycopeptide-Intermediate Staphylococcus aureus. Antimicrob Agents Chemother 2008; 52(7):2538-2543.","DOI":"10.1128\/AAC.00510-07"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Gerber P, Stucki A, Acosta F, Cottagnoud M, and Cottagnoud P. Daptomycin is more efficacious than vancomycin against a methicillin-susceptible Staphylococcus aureus in experimental meningitis. J Antimicrob Chemother 2006; 57(4):720-723.","DOI":"10.1093\/jac\/dkl007"},{"key":"16","unstructured":"16. Lambert M. IDSA guidelines on the treatment of MRSA infections in adults and children. American family physician 2011; 84(4):455."}],"container-title":["The Kurume Medical Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/kurumemedj\/66\/2\/66_MS662004\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,24]],"date-time":"2021-07-24T04:37:54Z","timestamp":1627101474000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/kurumemedj\/66\/2\/66_MS662004\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6,30]]},"references-count":16,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.2739\/kurumemedj.ms662004","relation":{},"ISSN":["0023-5679","1881-2090"],"issn-type":[{"value":"0023-5679","type":"print"},{"value":"1881-2090","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,6,30]]},"article-number":"MS662004"}}